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SUMMARY
Mouse cytomegalovirus (MCMV) grew to higher titres in spleen, liver, kidney and salivary gland of mice, and caused more sickness and death in susceptible (CD 1) mice following treatment with anti-interferon globulin (AIG). In the resistant (C3H) strain of mice, organ titres were higher following AIG treatment but there was no sickness or mortality. Spleen necrosis was more severe in AIG-treated mice, indicating that this necrosis was not caused by interferon-mediated activation of natural killer (NK) cells. CD1 mice developed a high level of NK activity during MCMV infection and this was greatly reduced by AIG treatment. AIG was equally effective in increasing virus titres in NK-deficient beige (bg/bg) C57 B1.6 mice which showed a low level of NK activity even after MCMV infection, suggesting that interferon protects against MCMV by its direct antiviral effect on cells rather than by activating NK cells.
Recent work on host defence against mouse cytomegalovirus (MCMV) has suggested that natural killer (NK) cells are important in resistance and that the NK activity in the spleen of mice is increased 1 to 2 days after infection. The resistance of different strains of mice moreover is generally correlated with the extent of NK activity , and NK-deficient beige (bg/bg) mice are more susceptible to infection . Quinnan et al. (1982) showed that CMV-infected mice developed higher organ titres and increased mortality when treated with hydrocortisone. Since hydrocortisone depressed NK activity without affecting interferon, antibody or cytotoxic T cell responses, they suggested that NK cells were important in defence against MCMV. Hydrocortisone, of course, has other actions, including the inhibition of inflammatory responses, but NK cells, if they kill virus-infected cells, certainly constitute a defence mechanism that operates early after infection, before specific immune responses have been generated.
There have been conflicting reports about the role of interferon in defence against MCMV (Osborn & Medearis, 1966; Oie et al., 1975 ; Kern et al., 1978; Tarr et al., 1978) , but NK cells are activated by interferon (Gidlund et al., 1978; Herberman et al., 1979; Trinchieri et al., 1978) . Anti-interferon globulin (AIG) has been successfully used to study the part played by interferon in other virus infections (Gresser et al., 1976a, b; Virelizier & Gresser, 1978) , and we have used an anti-interferon globulin raised in sheep against mouse type 1 (alpha and beta) interferon. The mouse interferon used to immunize sheep was obtained from Swiss mouse C243 cells after the addition of Newcastle disease virus. Both anti-interferon and control sera were extensively adsorbed on mouse spleen cells and thymocytes and the globulin fraction precipitated. The interferon-neutralizing titre of the AIG was 1.5 x 10 -6 against 4 to 8 units of mouse type 1 interferon. The regime and dose of AIG used in this study have been demonstrated previously to abolish endogenous serum interferon (Gresser et al., 1976 a, b; Virelizier & Gresser, 1978) . The Osborn strain of MCMV (Chong et al., 1981) was used throughout this study as a salivary gland virus preparation. The SPF Charles Rivers CD1 outbred mice were bred at Guy's Hospital Medical School. C3H mice were obtained from Bantin and Kingman (The Field Station, Aldborough, Hull, U.K.) and inbred C57 B 1.6, bg/bg genotype, mice were from Olac '1976' Ltd (Blackthorn, Oxfordshire, U.K.).
Four-week-old CD1 mice (susceptible) were given 0.1 ml of AIG intravenously 1 h before being infected intraperitoneally with 106 p.f.u, of Osborn strain salivary gland MCMV. Controls received normal sheep globulin (NSG) instead of AIG, and 4 or 5 days after infection all mice were killed and organs individually assayed for virus. Results showed that those treated 0022-1317/83/0000-5221 $02.0001983 SGM with AIG had five-to tenfold higher titres in liver and kidneys, but titres in spleen and salivary gland were not significantly different from controls. If NK cells contribute to resistance and AIG prevents their interferon-mediated activation, the effects should have been especially noticeable in the spleen, headquarters of NK cells. The experiment was repeated to study survival, and six out of ten AIG-treated mice died, compared with one out of ten controls (P < 0.02 by )~2 test).
AIG was next tested in 12-week-old resistant C3H mice and in 12-week-old susceptible CD1 mice. C3H mice are more than ten times as resistant to the lethal effect of intraperitoneal MCMV. To ensure that adequate serum levels of AIG were maintained throughout the experimental period, two doses were given on days 0 and 2. Organs were assayed 4 days after infection with MCMV, when AIG-treated CD1 mice were more ill than the controls and all C3H mice were well. The results (Table l) show that in both CD1 and C3H mice, organs, including the salivary gland (S.g.), contained three to eight times as much virus when AIG treatment was given.
Many strains of mice showed necrosis in the spleen, beginning 3 to 4 days after infection with large doses of MCMV (Mims & Gould, 1978) . This was not attributable to immune responses because it was unaffected by cyclophosphamide and anti-lymphocyte serum. The necrosis appeared to involve uninfected as well as infected cells and it was thought possible that it was due to massive local activation of NK cells. Spleens of mice in the above experiment were therefore examined histologically. In CD1 mice, spleen necrosis was much more severe in mice given AIG ; in C3H mice slight spleen necrosis occurred only in the AIG-treated group (Table  1) . This indicates that spleen necrosis is not attributable to interferon-mediated NK activity.
To test whether the AIG acted by preventing NK activation, an experiment was done with NK-deficient beige (bg/bg) C57 B1.6 mice. Eight-week-old mice were given 0.1 ml of AIG intravenously 1 h before being infected intraperitoneally with 2 x 104 p.f.u, of salivary gland virus. At 7 days after infection, all of the AIG-treated, but none of the control mice, were ill. All the mice were killed and organs were assayed for virus and examined histologically. Infected mice treated with AIG showed three-to tenfold higher virus titres in spleen, kidney, liver, lung and salivary gland, and also more severe spleen necrosis than control mice (Table 1 ). In addition, the AIG-treated mice developed focal infection, necrosis and mononuclear cell infiltrations in the kidney. Occasionally, infected tubular epithelial cells were seen by fluorescent antibody staining, a feature not previously described in MCMV-infected adult mice. This experiment suggests that interferon helps protect against MCMV by its direct antiviral effect on cells rather than by activating NK cells.
Further evidence for this was obtained when NK activity as well as organ titres were measured in AIG-treated mice. Ten-week-old beige mice were given 2 x 104 p.f.u, and 8-to 10-week-old CD1 mice 4 x 10 s p.f.u. MCMV intraperitoneally, 1 h after AIG treatment as described previously. For NK measurement, spleen cell pools from four mice were collected 3 days (beige) or 2 days (CDI) after infection. YAC-1 cells were obtained from Dr G. Bancroft (Department of Immunology, National Institute of Medical Research, Mill Hill, London U.K.), and were grown in RPMI 1640 medium supplemented with 10~ heated foetal calf serum. Target cells (10 6) were labelled with 50 gCi of chromium-51 (sodium chromate; Amersham International) in a volume of 0-3 ml. Target cells (2 x 104 in 100 lxl) were added to each well of microtitre plates (Falcon). Effector cells (10 6 in 100 lal) were added to replicates of six wells. Control wells contained either target cells and medium or target cells and 0.1 ~ Triton X-100 to obtain values for spontaneous SlCr release and total lysis. After 4 h of incubation at 37 °C in a humidified CO2 incubator, the supernatant fluid in each well was harvested after centrifugation at 1000 rev/min. Samples were counted in a Searle 1185 automatic gamma-counter. NK cytotoxicity was expressed as the percentage of specific release of s 1Cr and calculated as follows: ~o specific release = [(ct/min from well with effector cells -spontaneous release)/(total release -spontaneous release)] x 100. For sets of replicates, the ~ specific release _+ the standard error was calculated.
Others have shown that C57 B1.6 bg/bg mice generate an NK cell response following sublethal infections with MCMV but this is at a lower level than C57 B1.6 None 7 + 2 20 + 6 0 1 1 + * C3H and CDI mice were given two doses of AIG on day 0 and day 2. Beige mice were given a single dose of AIG. All mice were infected with sub-lethal doses of MCMV (4 x 105 p.f.u, for CD1, 8 x 105 p.f.u, for C3Hand 2 x 10 4 p.f.u, for beige mice).
1" Titres are given as the arithmetic means _+ the standard errors of the mean. All organs were assayed as 10~ (w/v) tissue homogenates.
Severity graded from + (just detectable) to + + + + (very severe). § In another experiment in which 4-week-old mice were given 10 6 p.f.u, of virus, there was no mortality in groups of 10 mice with or without a single dose of AIG. bg/+ controls in spite of the presence of much higher titres of interferon type 1 in the beige mouse.
The results of this study showed that interferon plays a protective role in MCMV infection. When endogenous interferon was blocked by anti-interferon globulin, the susceptible CD1 mice showed increased organ titres and significantly greater mortality. This was associated with depressed NK activation. The same result was obtained with infected beige mice, whose lowlevel NK activation was not affected by AIG treatment. This shows that interferon acts by a direct antiviral effect on cells rather than by activating NK cells. However, in resistant C3H mice infected with 106 p.f.u, of SGV (Table 1) , AIG treatment did not cause mortality.
Grundy (Chalmer) et al. (1982) have carried out experiments with the Smith strain of M CMV and AIG. Interferon produced by mouse L-929 cells treated with poly (rI). poly (rC) and DEAEdextran was used to immunize rabbits, and precipitated globulin from the serum was administered to mice. They, too, showed that AIG enhanced lethality and that blood and liver titres of virus were higher in C3H mice. In our experiments, however, we first carried out more extensive virus titration in organs of three different strains of mice; second, we studied the effects of AIG on spleen necrosis; and third, we have largely excluded interferon-mediated NK cell effects by demonstrating the same enhancement of infection in NK-deficient beige bg/bg mice. These studies were supported by MRC project grant no. G979/511/SB and in part by grants from DRET (contract no. 80.34. 522), INSERM (contract nos. 81.2008 INSERM (contract nos. 81. , 80. 1008 and DGRST (contract no. 80.70. 300 
